LLY

930.6

-5.49%↓

JNJ

238.04

-1.99%↓

ABBV

219.84

-0.68%↓

NVS

154.48

+0.12%↑

AZN

191.24

-0.38%↓

LLY

930.6

-5.49%↓

JNJ

238.04

-1.99%↓

ABBV

219.84

-0.68%↓

NVS

154.48

+0.12%↑

AZN

191.24

-0.38%↓

LLY

930.6

-5.49%↓

JNJ

238.04

-1.99%↓

ABBV

219.84

-0.68%↓

NVS

154.48

+0.12%↑

AZN

191.24

-0.38%↓

LLY

930.6

-5.49%↓

JNJ

238.04

-1.99%↓

ABBV

219.84

-0.68%↓

NVS

154.48

+0.12%↑

AZN

191.24

-0.38%↓

LLY

930.6

-5.49%↓

JNJ

238.04

-1.99%↓

ABBV

219.84

-0.68%↓

NVS

154.48

+0.12%↑

AZN

191.24

-0.38%↓

Search

McKesson Corp

Fechado

SetorSaúde

942.1 -0.11

Visão Geral

Variação de preço das ações

24h

Atual

Mín

926.2

Máximo

947.56

Indicadores-chave

By Trading Economics

Rendimento

40M

1.3B

Vendas

3B

106B

P/E

Médio do Setor

27.246

57.833

Rendimento de Dividendos

0.33

Margem de lucro

1.177

Funcionários

43,000

EBITDA

374M

1.8B

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

+5.71% upside

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

0.33%

2.47%

Próximos Ganhos

7 de mai. de 2026

Próxima data de dividendos

1 de abr. de 2026

Próxima data de ex-dividendo

1 de jun. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

11B

116B

Abertura anterior

942.21

Fecho anterior

942.1

Sentimento de Notícias

By Acuity

44%

56%

134 / 351 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Strong Bearish Evidence

McKesson Corp Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

17 de mar. de 2026, 22:42 UTC

Ganhos

Prudential PLC 2025 Adjusted Operating Profit Rises

17 de mar. de 2026, 21:40 UTC

Ganhos

Alimentation Couche-Tard Records Higher Profit, Revenue in 3Q

17 de mar. de 2026, 23:56 UTC

Conversa de Mercado

BHP's Next CEO Likely to Build On Existing Strategic Direction -- Market Talk

17 de mar. de 2026, 23:46 UTC

Conversa de Mercado

Nikkei May Rise After Recent Selloffs -- Market Talk

17 de mar. de 2026, 23:42 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

17 de mar. de 2026, 23:42 UTC

Conversa de Mercado

RBA's Return to Policy Tightening Will Work -- Market Talk

17 de mar. de 2026, 23:38 UTC

Conversa de Mercado

Gold Edges Lower on Possible Position Adjustments Before FOMC Decision -- Market Talk

17 de mar. de 2026, 23:24 UTC

Conversa de Mercado

Global Energy Roundup: Market Talk

17 de mar. de 2026, 23:24 UTC

Conversa de Mercado

New Woodside CEO Seen as Low-Risk Appointment -- Market Talk

17 de mar. de 2026, 22:22 UTC

Conversa de Mercado

BHP Hands Reins to Growth-Focused Executive -- Market Talk

17 de mar. de 2026, 22:20 UTC

Ganhos

Prudential PLC 2025 New Business Profit $2.78B Vs. $2.46B >2378.HK

17 de mar. de 2026, 22:20 UTC

Ganhos

Prudential PLC 2025 Adj Operating Profit $3.31B Vs. $3.13B >2378.HK

17 de mar. de 2026, 22:07 UTC

Ganhos

Nvidia Says It Is Restarting Production of AI Chips for Sale in China -- WSJ

17 de mar. de 2026, 22:05 UTC

Ganhos

ZTO Express (Cayman): Frank Zhen Wei to Resign From Board

17 de mar. de 2026, 22:04 UTC

Ganhos

ZTO Express (Cayman): Board Approves Repurchase of Up to $1.5B of Shares Over Next 24 Months >ZTO

17 de mar. de 2026, 22:03 UTC

Ganhos

ZTO Express (Cayman) Raises Semiannual Dividend to 39c Vs. 30c >ZTO

17 de mar. de 2026, 22:01 UTC

Ganhos

ZTO Express (Cayman) 4Q Adj EPS 47c >ZTO

17 de mar. de 2026, 22:01 UTC

Ganhos

ZTO Express (Cayman) 4Q Rev $2.08B >ZTO

17 de mar. de 2026, 22:01 UTC

Ganhos

ZTO Express (Cayman) 4Q EPS 47c >ZTO

17 de mar. de 2026, 21:26 UTC

Ganhos

Oklo Stock Wavers After Earnings, but the Nuclear Start-Up Has Good News -- Barrons.com

17 de mar. de 2026, 21:09 UTC

Ganhos

Couche-Tard: 12 Company-Operated Stores Acquired During 3Q

17 de mar. de 2026, 21:08 UTC

Ganhos

Couche-Tard 3Q Consolidated Same-Store Merchandise Revenue Up 2% >ATD.T

17 de mar. de 2026, 21:08 UTC

Ganhos

Couche-Tard 3Q Adj EPS 81c >ATD.T

17 de mar. de 2026, 21:07 UTC

Ganhos

Couche-Tard 3Q EPS 82c >ATD.T

17 de mar. de 2026, 21:06 UTC

Ganhos

Couche-Tard 3Q Rev $21.8B >ATD.T

17 de mar. de 2026, 21:05 UTC

Ganhos

Couche-Tard 3Q Adj EPS 81c >ATD.T

17 de mar. de 2026, 21:05 UTC

Ganhos

Couche-Tard 3Q Rev $21.8B >ATD.T

17 de mar. de 2026, 21:05 UTC

Ganhos

Couche-Tard 3Q EPS 82c >ATD.T

17 de mar. de 2026, 21:05 UTC

Ganhos

Couche-Tard 3Q Net $757.2M >ATD.T

17 de mar. de 2026, 20:50 UTC

Conversa de Mercado
Notícias Principais

Energy & Utilities Roundup: Market Talk

Comparação entre Pares

Variação de preço

McKesson Corp Previsão

Preço-alvo

By TipRanks

5.71% parte superior

Previsão para 12 meses

Média 997.1 USD  5.71%

Máximo 1,107 USD

Mínimo 885 USD

Com base em 11 analistas de Wall Street que oferecem metas de preço de 12 meses para McKesson Corp - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

11 ratings

9

Comprar

2

Manter

0

Vender

Pontuação Técnica

By Trading Central

681.92 / 707.28Suporte e Resistência

Curto Prazo

Strong Bearish Evidence

Médio Prazo

No Evidence

Longo Prazo

No Evidence

Sentimento

By Acuity

134 / 351 Ranking em Saúde

Sentimento de Notícias

Evidência de Tendência de Alta

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Acima da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre McKesson Corp

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners, and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
help-icon Live chat